Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Richard Price, MD

    TitleProfessor
    SchoolUCSF School of Medicine
    DepartmentNeurology
    Address1001 Potrero Ave, SFGH 1
    San Francisco CA 94143
    Phone415-206-4487

       ORNG Applications 
       Awarded Grants
       Global Health
       More Info

       Bibliographic 
       Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Gold JA, Grill M, Peterson J, Pilcher C, Lee E, Hecht FM, Fuchs D, Yiannoutsos CT, Price RW, Robertson K, Spudich S. Longitudinal Characterization of Depression and Mood States Beginning in Primary HIV Infection. AIDS Behav. 2014 Jun; 18(6):1124-32.
        View in: PubMed
      2. Price RW, Spudich SS, Peterson J, Joseph S, Fuchs D, Zetterberg H, Gisslén M, Swanstrom R. Evolving Character of Chronic Central Nervous System HIV Infection. Semin Neurol. 2014 Feb; 34(1):7-13.
        View in: PubMed
      3. Jessen Krut J, Mellberg T, Price RW, Hagberg L, Fuchs D, Rosengren L, Nilsson S, Zetterberg H, Gisslén M. Biomarker Evidence of Axonal Injury in Neuroasymptomatic HIV-1 Patients. PLoS One. 2014; 9(2):e88591.
        View in: PubMed
      4. Grill MF, Price RW. Central nervous system HIV-1 infection. Handb Clin Neurol. 2014; 123:487-505.
        View in: PubMed
      5. Dahl V, Gisslen M, Hagberg L, Peterson J, Shao W, Spudich S, Price RW, Palmer S. An Example of Genetically Distinct HIV Type 1 Variants in Cerebrospinal Fluid and Plasma During Suppressive Therapy. J Infect Dis. 2014 May; 209(10):1618-22.
        View in: PubMed
      6. Meyer AC, Boscardin WJ, Kwasa JK, Price RW. Is It Time to Rethink How Neuropsychological Tests Are Used to Diagnose Mild Forms of HIV-Associated Neurocognitive Disorders? Impact of False-Positive Rates on Prevalence and Power. Neuroepidemiology. 2013; 41(3-4):208-16.
        View in: PubMed
      7. Cettomai D, Kwasa JK, Birbeck GL, Price RW, Cohen CR, Bukusi EA, Kendi C, Meyer AC. Screening for HIV-associated peripheral neuropathy in resource-limited settings. Muscle Nerve. 2013 Oct; 48(4):516-24.
        View in: PubMed
      8. Grund B, Wright EJ, Brew BJ, Price RW, Roediger MP, Bain MP, Hoy JF, Shlay JC, Vjecha MJ, Robertson KR. Improved neurocognitive test performance in both arms of the SMART study: impact of practice effect. J Neurovirol. 2013 Aug; 19(4):383-92.
        View in: PubMed
      9. Price RW, Peterson J, Fuchs D, Angel TE, Zetterberg H, Hagberg L, Spudich S, Smith RD, Jacobs JM, Brown JN, Gisslen M. Approach to Cerebrospinal Fluid (CSF) Biomarker Discovery and Evaluation in HIV Infection. J Neuroimmune Pharmacol. 2013 Dec; 8(5):1147-58.
        View in: PubMed
      10. Yilmaz A, Yiannoutsos CT, Fuchs D, Price RW, Crozier K, Hagberg L, Spudich S, Gisslén M. Cerebrospinal fluid neopterin decay characteristics after initiation of antiretroviral therapy. J Neuroinflammation. 2013; 10:62.
        View in: PubMed
      11. Yukl SA, Boritz E, Busch M, Bentsen C, Chun TW, Douek D, Eisele E, Haase A, Ho YC, Hütter G, Justement JS, Keating S, Lee TH, Li P, Murray D, Palmer S, Pilcher C, Pillai S, Price RW, Rothenberger M, Schacker T, Siliciano J, Siliciano R, Sinclair E, Strain M, Wong J, Richman D, Deeks SG. Challenges in detecting HIV persistence during potentially curative interventions: a study of the Berlin patient. PLoS Pathog. 2013; 9(5):e1003347.
        View in: PubMed
      12. Dahl V, Peterson J, Spudich S, Lee E, Shacklett BL, Price RW, Palmer S. Single-copy assay quantification of HIV-1 RNA in paired cerebrospinal fluid and plasma samples from elite controllers. AIDS. 2013 Apr 24; 27(7):1145-9.
        View in: PubMed
      13. Peluso MJ, Meyerhoff DJ, Price RW, Peterson J, Lee E, Young AC, Walter R, Fuchs D, Brew BJ, Cinque P, Robertson K, Hagberg L, Zetterberg H, Gisslén M, Spudich S. Cerebrospinal fluid and neuroimaging biomarker abnormalities suggest early neurological injury in a subset of individuals during primary HIV infection. J Infect Dis. 2013 Jun 1; 207(11):1703-12.
        View in: PubMed
      14. Krut JJ, Zetterberg H, Blennow K, Cinque P, Hagberg L, Price RW, Studahl M, Gisslén M. Cerebrospinal fluid Alzheimer's biomarker profiles in CNS infections. J Neurol. 2013 Feb; 260(2):620-6.
        View in: PubMed
      15. Price RW, Swanstrom R. Targeting chronic central nervous system HIV infection. Antivir Ther. 2012; 17(7):1227-31.
        View in: PubMed
      16. Peluso MJ, Ferretti F, Peterson J, Lee E, Fuchs D, Boschini A, Gisslén M, Angoff N, Price RW, Cinque P, Spudich S. Cerebrospinal fluid HIV escape associated with progressive neurologic dysfunction in patients on antiretroviral therapy with well controlled plasma viral load. AIDS. 2012 Sep 10; 26(14):1765-74.
        View in: PubMed
      17. Fanara P, Wong PY, Husted KH, Liu S, Liu VM, Kohlstaedt LA, Riiff T, Protasio JC, Boban D, Killion S, Killian M, Epling L, Sinclair E, Peterson J, Price RW, Cabin DE, Nussbaum RL, Brühmann J, Brandt R, Christine CW, Aminoff MJ, Hellerstein MK. Cerebrospinal fluid-based kinetic biomarkers of axonal transport in monitoring neurodegeneration. J Clin Invest. 2012 Sep 4; 122(9):3159-69.
        View in: PubMed
      18. Angel TE, Jacobs JM, Spudich SS, Gritsenko MA, Fuchs D, Liegler T, Zetterberg H, Camp DG, Price RW, Smith RD. The cerebrospinal fluid proteome in HIV infection: change associated with disease severity. Clin Proteomics. 2012; 9(1):3.
        View in: PubMed
      19. Kwasa J, Cettomai D, Lwanya E, Osiemo D, Oyaro P, Birbeck GL, Price RW, Bukusi EA, Cohen CR, Meyer AC. Lessons learned developing a diagnostic tool for HIV-associated dementia feasible to implement in resource-limited settings: pilot testing in Kenya. PLoS One. 2012; 7(3):e32898.
        View in: PubMed
      20. Gisslén M, Price RW, Nilsson S. The definition of HIV-associated neurocognitive disorders: are we overestimating the real prevalence? BMC Infect Dis. 2011; 11:356.
        View in: PubMed
      21. Yilmaz A, Price RW, Gisslén M. Antiretroviral drug treatment of CNS HIV-1 infection. J Antimicrob Chemother. 2012 Feb; 67(2):299-311.
        View in: PubMed
      22. Dahl V, Lee E, Peterson J, Spudich SS, Leppla I, Sinclair E, Fuchs D, Palmer S, Price RW. Raltegravir treatment intensification does not alter cerebrospinal fluid HIV-1 infection or immunoactivation in subjects on suppressive therapy. J Infect Dis. 2011 Dec 15; 204(12):1936-45.
        View in: PubMed
      23. Schnell G, Joseph S, Spudich S, Price RW, Swanstrom R. HIV-1 replication in the central nervous system occurs in two distinct cell types. PLoS Pathog. 2011 Oct; 7(10):e1002286.
        View in: PubMed
      24. Spudich S, Gisslen M, Hagberg L, Lee E, Liegler T, Brew B, Fuchs D, Tambussi G, Cinque P, Hecht FM, Price RW. Central nervous system immune activation characterizes primary human immunodeficiency virus 1 infection even in participants with minimal cerebrospinal fluid viral burden. J Infect Dis. 2011 Sep 1; 204(5):753-60.
        View in: PubMed
      25. Robertson K, Kumwenda J, Supparatpinyo K, Jiang JH, Evans S, Campbell TB, Price RW, Murphy R, Hall C, Marra CM, Marcus C, Berzins B, Masih R, Santos B, Silva MT, Kumarasamy N, Walawander A, Nair A, Tripathy S, Kanyama C, Hosseinipour M, Montano S, La Rosa A, Amod F, Sanne I, Firnhaber C, Hakim J, Brouwers P. A multinational study of neurological performance in antiretroviral therapy-naïve HIV-1-infected persons in diverse resource-constrained settings. J Neurovirol. 2011 Oct; 17(5):438-47.
        View in: PubMed
      26. Cettomai D, Kwasa J, Birbeck GL, Price RW, Bukusi EA, Meyer AC. Training needs and evaluation of a neuro-HIV training module for non-physician healthcare workers in western Kenya. J Neurol Sci. 2011 Aug 15; 307(1-2):92-6.
        View in: PubMed
      27. Ho EL, Spudich SS, Lee E, Fuchs D, Sinclair E, Price RW. Minocycline fails to modulate cerebrospinal fluid HIV infection or immune activation in chronic untreated HIV-1 infection: results of a pilot study. AIDS Res Ther. 2011; 8:17.
        View in: PubMed
      28. Price RW. Impact of antiretroviral therapy on HIV-related brain injury. Clin Infect Dis. 2011 Jan 15; 52(2):244-7.
        View in: PubMed
      29. Cettomai D, Kwasa J, Kendi C, Birbeck GL, Price RW, Bukusi EA, Cohen CR, Meyer AC. Utility of quantitative sensory testing and screening tools in identifying HIV-associated peripheral neuropathy in Western Kenya: pilot testing. PLoS One. 2010; 5(12):e14256.
        View in: PubMed
      30. Edén A, Fuchs D, Hagberg L, Nilsson S, Spudich S, Svennerholm B, Price RW, Gisslén M. HIV-1 viral escape in cerebrospinal fluid of subjects on suppressive antiretroviral treatment. J Infect Dis. 2010 Dec 15; 202(12):1819-25.
        View in: PubMed
      31. Wright EJ, Grund B, Robertson K, Brew BJ, Roediger M, Bain MP, Drummond F, Vjecha MJ, Hoy J, Miller C, Penalva de Oliveira AC, Pumpradit W, Shlay JC, El-Sadr W, Price RW. Cardiovascular risk factors associated with lower baseline cognitive performance in HIV-positive persons. Neurology. 2010 Sep 7; 75(10):864-73.
        View in: PubMed
      32. Hagberg L, Cinque P, Gisslen M, Brew BJ, Spudich S, Bestetti A, Price RW, Fuchs D. Cerebrospinal fluid neopterin: an informative biomarker of central nervous system immune activation in HIV-1 infection. AIDS Res Ther. 2010; 7:15.
        View in: PubMed
      33. Probasco JC, Deeks SG, Lee E, Hoh R, Hunt PW, Liegler T, Price RW, Spudich SS. Cerebrospinal fluid in HIV-1 systemic viral controllers: absence of HIV-1 RNA and intrathecal inflammation. AIDS. 2010 Apr 24; 24(7):1001-5.
        View in: PubMed
      34. Gisslén M, Krut J, Andreasson U, Blennow K, Cinque P, Brew BJ, Spudich S, Hagberg L, Rosengren L, Price RW, Zetterberg H. Amyloid and tau cerebrospinal fluid biomarkers in HIV infection. BMC Neurol. 2009; 9:63.
        View in: PubMed
      35. Schnell G, Price RW, Swanstrom R, Spudich S. Compartmentalization and clonal amplification of HIV-1 variants in the cerebrospinal fluid during primary infection. J Virol. 2010 Mar; 84(5):2395-407.
        View in: PubMed
      36. Franciotta D, Bestetti A, Sala S, Perucca P, Jarius S, Price RW, Di Stefano AL, Cinque P. Broad screening for human herpesviridae DNA in multiple sclerosis cerebrospinal fluid and serum. Acta Neurol Belg. 2009 Dec; 109(4):277-82.
        View in: PubMed
      37. Cinque P, Koralnik IJ, Gerevini S, Miro JM, Price RW. Progressive multifocal leukoencephalopathy in HIV-1 infection. Lancet Infect Dis. 2009 Oct; 9(10):625-36.
        View in: PubMed
      38. Yilmaz A, Gisslén M, Spudich S, Lee E, Jayewardene A, Aweeka F, Price RW. Raltegravir cerebrospinal fluid concentrations in HIV-1 infection. PLoS One. 2009; 4(9):e6877.
        View in: PubMed
      39. Harrington PR, Schnell G, Letendre SL, Ritola K, Robertson K, Hall C, Burch CL, Jabara CB, Moore DT, Ellis RJ, Price RW, Swanstrom R. Cross-sectional characterization of HIV-1 env compartmentalization in cerebrospinal fluid over the full disease course. AIDS. 2009 May 15; 23(8):907-15.
        View in: PubMed
      40. Schnell G, Spudich S, Harrington P, Price RW, Swanstrom R. Compartmentalized human immunodeficiency virus type 1 originates from long-lived cells in some subjects with HIV-1-associated dementia. PLoS Pathog. 2009 Apr; 5(4):e1000395.
        View in: PubMed
      41. Yilmaz A, Izadkhashti A, Price RW, Mallon PW, De Meulder M, Timmerman P, Gisslén M. Darunavir concentrations in cerebrospinal fluid and blood in HIV-1-infected individuals. AIDS Res Hum Retroviruses. 2009 Apr; 25(4):457-61.
        View in: PubMed
      42. Ince WL, Harrington PR, Schnell GL, Patel-Chhabra M, Burch CL, Menezes P, Price RW, Eron JJ, Swanstrom RI. Major coexisting human immunodeficiency virus type 1 env gene subpopulations in the peripheral blood are produced by cells with similar turnover rates and show little evidence of genetic compartmentalization. J Virol. 2009 May; 83(9):4068-80.
        View in: PubMed
      43. Buescher JL, Duan F, Sun J, Price RW, Ikezu T. OTK18 levels in plasma and cerebrospinal fluid correlate with viral load and CD8 T-cells in normal and AIDS patients. J Neuroimmune Pharmacol. 2008 Dec; 3(4):230-5.
        View in: PubMed
      44. Probasco JC, Spudich SS, Critchfield J, Lee E, Lollo N, Deeks SG, Price RW. Failure of atorvastatin to modulate CSF HIV-1 infection: results of a pilot study. Neurology. 2008 Aug 12; 71(7):521-4.
        View in: PubMed
      45. Price RW, Spudich S. Antiretroviral therapy and central nervous system HIV type 1 infection. J Infect Dis. 2008 May 15; 197 Suppl 3:S294-306.
        View in: PubMed
      46. Lifson AR. Determination of the underlying cause of death in three multicenter international HIV clinical trials. HIV Clin Trials. 2008 May-Jun; 9(3):177-85.
        View in: PubMed
      47. Sinclair E, Ronquillo R, Lollo N, Deeks SG, Hunt P, Yiannoutsos CT, Spudich S, Price RW. Antiretroviral treatment effect on immune activation reduces cerebrospinal fluid HIV-1 infection. J Acquir Immune Defic Syndr. 2008 Apr 15; 47(5):544-52.
        View in: PubMed
      48. Yilmaz A, Price RW, Spudich S, Fuchs D, Hagberg L, Gisslén M. Persistent intrathecal immune activation in HIV-1-infected individuals on antiretroviral therapy. J Acquir Immune Defic Syndr. 2008 Feb 1; 47(2):168-73.
        View in: PubMed
      49. Price RW, Parham R, Kroll JL, Wring SA, Baker B, Sailstad J, Hoh R, Liegler T, Spudich S, Kuritzkes DR, Deeks SG. Enfuvirtide cerebrospinal fluid (CSF) pharmacokinetics and potential use in defining CSF HIV-1 origin. Antivir Ther. 2008; 13(3):369-74.
        View in: PubMed
      50. Edén A, Price RW, Spudich S, Fuchs D, Hagberg L, Gisslén M. Immune activation of the central nervous system is still present after >4 years of effective highly active antiretroviral therapy. J Infect Dis. 2007 Dec 15; 196(12):1779-83.
        View in: PubMed
      51. Price RW, Epstein LG, Becker JT, Cinque P, Gisslen M, Pulliam L, McArthur JC. Biomarkers of HIV-1 CNS infection and injury. Neurology. 2007 Oct 30; 69(18):1781-8.
        View in: PubMed
      52. Mellgren A, Price RW, Hagberg L, Rosengren L, Brew BJ, Gisslén M. Antiretroviral treatment reduces increased CSF neurofilament protein (NFL) in HIV-1 infection. Neurology. 2007 Oct 9; 69(15):1536-41.
        View in: PubMed
      53. Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, Gisslen M, Grant I, Heaton RK, Joseph J, Marder K, Marra CM, McArthur JC, Nunn M, Price RW, Pulliam L, Robertson KR, Sacktor N, Valcour V, Wojna VE. Updated research nosology for HIV-associated neurocognitive disorders. Neurology. 2007 Oct 30; 69(18):1789-99.
        View in: PubMed
      54. Gisslen M, Hagberg L, Brew BJ, Cinque P, Price RW, Rosengren L. Elevated cerebrospinal fluid neurofilament light protein concentrations predict the development of AIDS dementia complex. J Infect Dis. 2007 Jun 15; 195(12):1774-8.
        View in: PubMed
      55. Abdulle S, Mellgren A, Brew BJ, Cinque P, Hagberg L, Price RW, Rosengren L, Gisslén M. CSF neurofilament protein (NFL) -- a marker of active HIV-related neurodegeneration. J Neurol. 2007 Aug; 254(8):1026-32.
        View in: PubMed
      56. Brew BJ, Halman M, Catalan J, Sacktor N, Price RW, Brown S, Atkinson H, Clifford DB, Simpson D, Torres G, Hall C, Power C, Marder K, Mc Arthur JC, Symonds W, Romero C. Factors in AIDS dementia complex trial design: results and lessons from the abacavir trial. PLoS Clin Trials. 2007; 2(3):e13.
        View in: PubMed
      57. Cinque P, Brew BJ, Gisslen M, Hagberg L, Price RW. Cerebrospinal fluid markers in central nervous system HIV infection and AIDS dementia complex. Handb Clin Neurol. 2007; 85:261-300.
        View in: PubMed
      58. Spudich S, Lollo N, Liegler T, Deeks SG, Price RW. Treatment benefit on cerebrospinal fluid HIV-1 levels in the setting of systemic virological suppression and failure. J Infect Dis. 2006 Dec 15; 194(12):1686-96.
        View in: PubMed
      59. Robertson KR, Parsons TD, Sidtis JJ, Hanlon Inman T, Robertson WT, Hall CD, Price RW. Timed Gait test: normative data for the assessment of the AIDS dementia complex. J Clin Exp Neuropsychol. 2006 Oct; 28(7):1053-64.
        View in: PubMed
      60. Gisslen M, Hagberg L, Rosengren L, Brew BJ, Cinque P, Spudich S, Price RW. Defining and evaluating HIV-related neurodegenerative disease and its treatment targets: a combinatorial approach to use of cerebrospinal fluid molecular biomarkers. J Neuroimmune Pharmacol. 2007 Mar; 2(1):112-9.
        View in: PubMed
      61. Hunt PW, Harrigan PR, Huang W, Bates M, Williamson DW, McCune JM, Price RW, Spudich SS, Lampiris H, Hoh R, Leigler T, Martin JN, Deeks SG. Prevalence of CXCR4 tropism among antiretroviral-treated HIV-1-infected patients with detectable viremia. J Infect Dis. 2006 Oct 1; 194(7):926-30.
        View in: PubMed
      62. Spudich SS, Nilsson AC, Lollo ND, Liegler TJ, Petropoulos CJ, Deeks SG, Paxinos EE, Price RW. Cerebrospinal fluid HIV infection and pleocytosis: relation to systemic infection and antiretroviral treatment. BMC Infect Dis. 2005; 5:98.
        View in: PubMed
      63. Neuenburg JK, Furlan S, Bacchetti P, Price RW, Grant RM. Enrichment of activated monocytes in cerebrospinal fluid during antiretroviral therapy. AIDS. 2005 Sep 2; 19(13):1351-9.
        View in: PubMed
      64. Gisslén M, Rosengren L, Hagberg L, Deeks SG, Price RW. Cerebrospinal fluid signs of neuronal damage after antiretroviral treatment interruption in HIV-1 infection. AIDS Res Ther. 2005 Aug 18; 2:6.
        View in: PubMed
      65. Cinque P, Bestetti A, Marenzi R, Sala S, Gisslen M, Hagberg L, Price RW. Cerebrospinal fluid interferon-gamma-inducible protein 10 (IP-10, CXCL10) in HIV-1 infection. J Neuroimmunol. 2005 Nov; 168(1-2):154-63.
        View in: PubMed
      66. Cysique LA, Brew BJ, Halman M, Catalan J, Sacktor N, Price RW, Brown S, Atkinson JH, Clifford DB, Simpson D, Torres G, Hall C, Power C, Marder K, McArthur JC, Symonds W, Romero C. Undetectable cerebrospinal fluid HIV RNA and beta-2 microglobulin do not indicate inactive AIDS dementia complex in highly active antiretroviral therapy-treated patients. J Acquir Immune Defic Syndr. 2005 Aug 1; 39(4):426-9.
        View in: PubMed
      67. Neuenburg JK, Cho TA, Nilsson A, Bredt BM, Hebert SJ, Grant RM, Price RW. T-cell activation and memory phenotypes in cerebrospinal fluid during HIV infection. J Acquir Immune Defic Syndr. 2005 May 1; 39(1):16-22.
        View in: PubMed
      68. Price RW, Robertson K. Editorial comment: déjà vu--neurologic complications of HIV infection in the expanding epidemic. AIDS Read. 2005 Mar; 15(3):144.
        View in: PubMed
      69. Spudich SS, Huang W, Nilsson AC, Petropoulos CJ, Liegler TJ, Whitcomb JM, Price RW. HIV-1 chemokine coreceptor utilization in paired cerebrospinal fluid and plasma samples: a survey of subjects with viremia. J Infect Dis. 2005 Mar 15; 191(6):890-8.
        View in: PubMed
      70. Cinque P, Robertson K, Antinori A, Price RW. Neurological complications of HIV infection and AIDS: current and future perspectives. J Neurovirol. 2005; 11 Suppl 3:1-5.
        View in: PubMed
      71. Mellgren A, Antinori A, Cinque P, Price RW, Eggers C, Hagberg L, Gisslén M. Cerebrospinal fluid HIV-1 infection usually responds well to antiretroviral treatment. Antivir Ther. 2005; 10(6):701-7.
        View in: PubMed
      72. Sidenius N, Nebuloni M, Sala S, Zerbi P, Price RW, Gisslen M, Hagberg L, Vago L, Lazzarin A, Blasi F, Cinque P. Expression of the urokinase plasminogen activator and its receptor in HIV-1-associated central nervous system disease. J Neuroimmunol. 2004 Dec; 157(1-2):133-9.
        View in: PubMed
      73. Neuenburg JK, Sinclair E, Nilsson A, Kreis C, Bacchetti P, Price RW, Grant RM. HIV-producing T cells in cerebrospinal fluid. J Acquir Immune Defic Syndr. 2004 Oct 1; 37(2):1237-44.
        View in: PubMed
      74. Kao AW, Price RW. Chemokine receptors, neural progenitor cells, and the AIDS dementia complex. J Infect Dis. 2004 Jul 15; 190(2):211-5.
        View in: PubMed
      75. Shacklett BL, Cox CA, Wilkens DT, Karl Karlsson R, Nilsson A, Nixon DF, Price RW. Increased adhesion molecule and chemokine receptor expression on CD8+ T cells trafficking to cerebrospinal fluid in HIV-1 infection. J Infect Dis. 2004 Jun 15; 189(12):2202-12.
        View in: PubMed
      76. Cinque P, Nebuloni M, Santovito ML, Price RW, Gisslen M, Hagberg L, Bestetti A, Vago G, Lazzarin A, Blasi F, Sidenius N. The urokinase receptor is overexpressed in the AIDS dementia complex and other neurological manifestations. Ann Neurol. 2004 May; 55(5):687-94.
        View in: PubMed
      77. Valle M, Price RW, Nilsson A, Heyes M, Verotta D. CSF quinolinic acid levels are determined by local HIV infection: cross-sectional analysis and modelling of dynamics following antiretroviral therapy. Brain. 2004 May; 127(Pt 5):1047-60.
        View in: PubMed
      78. Price RW, Deeks SG. Antiretroviral drug treatment interruption in human immunodeficiency virus-infected adults: Clinical and pathogenetic implications for the central nervous system. J Neurovirol. 2004; 10 Suppl 1:44-51.
        View in: PubMed
      79. Neuenburg JK, Brodt HR, Herndier BG, Bickel M, Bacchetti P, Price RW, Grant RM, Schlote W. HIV-related neuropathology, 1985 to 1999: rising prevalence of HIV encephalopathy in the era of highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2002 Oct 1; 31(2):171-7.
        View in: PubMed
      80. Aberg JA, Price RW, Heeren DM, Bredt B. A pilot study of the discontinuation of antifungal therapy for disseminated cryptococcal disease in patients with acquired immunodeficiency syndrome, following immunologic response to antiretroviral therapy. J Infect Dis. 2002 Apr 15; 185(8):1179-82.
        View in: PubMed
      81. Price RW. Screening for the AIDS dementia complex. AIDS Read. 2002 Jan; 12(1):32-3.
        View in: PubMed
      82. Price RW, Paxinos EE, Grant RM, Drews B, Nilsson A, Hoh R, Hellmann NS, Petropoulos CJ, Deeks SG. Cerebrospinal fluid response to structured treatment interruption after virological failure. AIDS. 2001 Jul 6; 15(10):1251-9.
        View in: PubMed
      83. Lanier ER, Sturge G, McClernon D, Brown S, Halman M, Sacktor N, McArthur J, Atkinson JH, Clifford D, Price RW, Simpson D, Torres G, Catalan J, Marder K, Power C, Hall C, Romero C, Brew B. HIV-1 reverse transcriptase sequence in plasma and cerebrospinal fluid of patients with AIDS dementia complex treated with Abacavir. AIDS. 2001 Apr 13; 15(6):747-51.
        View in: PubMed
      84. Price RW. The two faces of HIV infection of cerebrospinal fluid. Trends Microbiol. 2000 Sep; 8(9):387-91.
        View in: PubMed
      85. Eberly LE, Ohman PA, Neaton JD, Price RW, Abrams DI. Kaposi's sarcoma and central nervous system disease: a real association or an artifact of the control group? Terry Beirn Community Programs for Clinical Research on AIDS. AIDS. 2000 May 26; 14(8):995-1000.
        View in: PubMed
      86. Price RW, Yiannoutsos CT, Clifford DB, Zaborski L, Tselis A, Sidtis JJ, Cohen B, Hall CD, Erice A, Henry K. Neurological outcomes in late HIV infection: adverse impact of neurological impairment on survival and protective effect of antiviral therapy. AIDS Clinical Trial Group and Neurological AIDS Research Consortium study team. AIDS. 1999 Sep 10; 13(13):1677-85.
        View in: PubMed
      87. Staprans S, Marlowe N, Glidden D, Novakovic-Agopian T, Grant RM, Heyes M, Aweeka F, Deeks S, Price RW. Time course of cerebrospinal fluid responses to antiretroviral therapy: evidence for variable compartmentalization of infection. AIDS. 1999 Jun 18; 13(9):1051-61.
        View in: PubMed
      88. Aweeka F, Jayewardene A, Staprans S, Bellibas SE, Kearney B, Lizak P, Novakovic-Agopian T, Price RW. Failure to detect nelfinavir in the cerebrospinal fluid of HIV-1--infected patients with and without AIDS dementia complex. J Acquir Immune Defic Syndr Hum Retrovirol. 1999 Jan 1; 20(1):39-43.
        View in: PubMed
      89. Green LA, Rhame FS, Price RW, Perlman DC, Capps LG, Sampson JH, Deyton LR, Schnittman SM, Fisher EJ, Bartsch GE, Krum EA, Neaton JD. Experience with a cross-study endpoint review committee for AIDS clinical trials. Terry Beirn Community Programs for Clinical Research on AIDS. AIDS. 1998 Oct 22; 12(15):1983-90.
        View in: PubMed
      90. Price RW. Neuropathy complicating diffuse infiltrative lymphocytosis. Lancet. 1998 Aug 22; 352(9128):592-4.
        View in: PubMed
      91. Price RW, Staprans S. Measuring the "viral load" in cerebrospinal fluid in human immunodeficiency virus infection: window into brain infection? Ann Neurol. 1997 Nov; 42(5):675-8.
        View in: PubMed
      92. Sidtis JJ, Dafni U, Slasor P, Hall C, Price RW, Kieburtz K, Tucker T, Clifford DB. Stable neurological function in subjects treated with 2'3'-dideoxyinosine. J Neurovirol. 1997 Jun; 3(3):233-40.
        View in: PubMed
      93. Price RW. Neurological complications of HIV infection. Lancet. 1996 Aug 17; 348(9025):445-52.
        View in: PubMed
      94. Rottenberg DA, Sidtis JJ, Strother SC, Schaper KA, Anderson JR, Nelson MJ, Price RW. Abnormal cerebral glucose metabolism in HIV-1 seropositive subjects with and without dementia. J Nucl Med. 1996 Jul; 37(7):1133-41.
        View in: PubMed
      95. Brew BJ, Wesselingh SL, Gonzales M, Heyes MP, Price RW. Managing HIV. Part 3: Mechanisms of diseases. 3.7 How HIV leads to neurological disease. Med J Aust. 1996 Feb 19; 164(4):233-4.
        View in: PubMed
      96. Price RW. AIDS dementia complex: a complex, slow virus "model" of acquired genetic neurodegenerative disease. Cold Spring Harb Symp Quant Biol. 1996; 61:759-70.
        View in: PubMed
      97. Price RW. The cellular basis of central nervous system HIV-1 infection and the AIDS dementia complex: introduction. J NeuroAIDS. 1996; 1(1):1-29.
        View in: PubMed
      98. Brew BJ, Rosenblum M, Cronin K, Price RW. AIDS dementia complex and HIV-1 brain infection: clinical-virological correlations. Ann Neurol. 1995 Oct; 38(4):563-70.
        View in: PubMed
      99. Price RW. Management of AIDS dementia complex and HIV-1 infection of the nervous system. AIDS. 1995; 9 Suppl A:S221-36.
        View in: PubMed
      100. Price RW. AIDS dementia complex and HIV-1 brain infection: a pathogenetic framework for treatment and evaluation. Curr Top Microbiol Immunol. 1995; 202:33-54.
        View in: PubMed
      101. Brew BJ, Paul MO, Nakajima G, Khan A, Gallardo H, Price RW. Cerebrospinal fluid HIV-1 p24 antigen and culture: sensitivity and specificity for AIDS-dementia complex. J Neurol Neurosurg Psychiatry. 1994 Jul; 57(7):784-9.
        View in: PubMed
      102. Price RW. Understanding the AIDS dementia complex (ADC). The challenge of HIV and its effects on the central nervous system. Res Publ Assoc Res Nerv Ment Dis. 1994; 72:1-45.
        View in: PubMed
      103. Sidtis JJ, Gatsonis C, Price RW, Singer EJ, Collier AC, Richman DD, Hirsch MS, Schaerf FW, Fischl MA, Kieburtz K, et al. Zidovudine treatment of the AIDS dementia complex: results of a placebo-controlled trial. AIDS Clinical Trials Group. Ann Neurol. 1993 Apr; 33(4):343-9.
        View in: PubMed
      104. Li Y, Hui H, Burgess CJ, Price RW, Sharp PM, Hahn BH, Shaw GM. Complete nucleotide sequence, genome organization, and biological properties of human immunodeficiency virus type 1 in vivo: evidence for limited defectiveness and complementation. J Virol. 1992 Nov; 66(11):6587-600.
        View in: PubMed
      105. Shaskan EG, Brew BJ, Rosenblum M, Thompson RM, Price RW. Increased neopterin levels in brains of patients with human immunodeficiency virus type 1 infection. J Neurochem. 1992 Oct; 59(4):1541-6.
        View in: PubMed
      106. Heyes MP, Brew BJ, Saito K, Quearry BJ, Price RW, Lee K, Bhalla RB, Der M, Markey SP. Inter-relationships between quinolinic acid, neuroactive kynurenines, neopterin and beta 2-microglobulin in cerebrospinal fluid and serum of HIV-1-infected patients. J Neuroimmunol. 1992 Sep; 40(1):71-80.
        View in: PubMed
      107. Shaskan EG, Thompson RM, Price RW. Undetectable tumor necrosis factor-alpha in spinal fluid from HIV-1-infected patients. Ann Neurol. 1992 Jun; 31(6):687-9.
        View in: PubMed
      108. Brew BJ, Bhalla RB, Paul M, Sidtis JJ, Keilp JJ, Sadler AE, Gallardo H, McArthur JC, Schwartz MK, Price RW. Cerebrospinal fluid beta 2-microglobulin in patients with AIDS dementia complex: an expanded series including response to zidovudine treatment. AIDS. 1992 May; 6(5):461-5.
        View in: PubMed
      109. Rosenblum MK, Brew BJ, Hahn B, Shaw G, Haase A, Maroushek S, Price RW. Human T-lymphotropic virus type I-associated myelopathy in patients with the acquired immunodeficiency syndrome. Hum Pathol. 1992 May; 23(5):513-9.
        View in: PubMed
      110. Westervelt P, Trowbridge DB, Epstein LG, Blumberg BM, Li Y, Hahn BH, Shaw GM, Price RW, Ratner L. Macrophage tropism determinants of human immunodeficiency virus type 1 in vivo. J Virol. 1992 Apr; 66(4):2577-82.
        View in: PubMed
      111. Spencer DC, Price RW. Human immunodeficiency virus and the central nervous system. Annu Rev Microbiol. 1992; 46:655-93.
        View in: PubMed
      112. Sweeney JA, Brew BJ, Keilp JG, Sidtis JJ, Price RW. Pursuit eye movement dysfunction in HIV-1 seropositive individuals. J Psychiatry Neurosci. 1991 Dec; 16(5):247-52.
        View in: PubMed
      113. Li Y, Kappes JC, Conway JA, Price RW, Shaw GM, Hahn BH. Molecular characterization of human immunodeficiency virus type 1 cloned directly from uncultured human brain tissue: identification of replication-competent and -defective viral genomes. J Virol. 1991 Aug; 65(8):3973-85.
        View in: PubMed
      114. Devinsky O, Cho ES, Petito CK, Price RW. Herpes zoster myelitis. Brain. 1991 Jun; 114 ( Pt 3):1181-96.
        View in: PubMed
      115. Price RW, Sidtis JJ, Brew BJ. AIDS dementia complex and HIV-1 infection: a view from the clinic. Brain Pathol. 1991 Apr; 1(3):155-62.
        View in: PubMed
      116. Kaplan JE, Litchfield B, Rouault C, Lairmore MD, Luo CC, Williams L, Brew BJ, Price RW, Janssen R, Stoneburner R, et al. HTLV-I-associated myelopathy associated with blood transfusion in the United States: epidemiologic and molecular evidence linking donor and recipient. Neurology. 1991 Feb; 41(2 ( Pt 1)):192-7.
        View in: PubMed
      117. Heyes MP, Brew BJ, Martin A, Price RW, Salazar AM, Sidtis JJ, Yergey JA, Mouradian MM, Sadler AE, Keilp J, et al. Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurological status. Ann Neurol. 1991 Feb; 29(2):202-9.
        View in: PubMed
      118. Heyes MP, Brew B, Martin A, Markey SP, Price RW, Bhalla RB, Salazar A. Cerebrospinal fluid quinolinic acid concentrations are increased in acquired immune deficiency syndrome. Adv Exp Med Biol. 1991; 294:687-90.
        View in: PubMed
      119. Brew BJ, Bhalla RB, Paul M, Gallardo H, McArthur JC, Schwartz MK, Price RW. Cerebrospinal fluid neopterin in human immunodeficiency virus type 1 infection. Ann Neurol. 1990 Oct; 28(4):556-60.
        View in: PubMed
      120. Sidtis JJ, Price RW. Early HIV-1 infection and the AIDS dementia complex. Neurology. 1990 Feb; 40(2):323-6.
        View in: PubMed
      121. Price RW, Sidtis JJ. Evaluation of the AIDS dementia complex in clinical trials. J Acquir Immune Defic Syndr. 1990; 3 Suppl 2:S51-60.
        View in: PubMed
      122. Price RW, Brew BJ, Rosenblum M. The AIDS dementia complex and HIV-1 brain infection: a pathogenetic model of virus-immune interaction. Res Publ Assoc Res Nerv Ment Dis. 1990; 68:269-90.
        View in: PubMed
      123. Rosenblum M, Scheck AC, Cronin K, Brew BJ, Khan A, Paul M, Price RW. Dissociation of AIDS-related vacuolar myelopathy and productive HIV-1 infection of the spinal cord. Neurology. 1989 Jul; 39(7):892-6.
        View in: PubMed
      124. Brew BJ, Bhalla RB, Fleisher M, Paul M, Khan A, Schwartz MK, Price RW. Cerebrospinal fluid beta 2 microglobulin in patients infected with human immunodeficiency virus. Neurology. 1989 Jun; 39(6):830-4.
        View in: PubMed
      125. Janssen RS, Cornblath DR, Epstein LG, McArthur J, Price RW. Human immunodeficiency virus (HIV) infection and the nervous system: report from the American Academy of Neurology AIDS Task Force. Neurology. 1989 Jan; 39(1):119-22.
        View in: PubMed
      126. Brew BJ, Rosenblum M, Price RW. AIDS dementia complex and primary HIV brain infection. J Neuroimmunol. 1988 Dec; 20(2-3):133-40.
        View in: PubMed
      127. Price RW, Brew BJ. The AIDS dementia complex. J Infect Dis. 1988 Nov; 158(5):1079-83.
        View in: PubMed
      128. Brew BJ, Sidtis JJ, Rosenblum M, Price RW. AIDS dementia complex. J R Coll Physicians Lond. 1988 Jul; 22(3):140-4.
        View in: PubMed
      129. Price RW, Brew B. Management of the neurologic complications of HIV infection and AIDS. Infect Dis Clin North Am. 1988 Jun; 2(2):359-72.
        View in: PubMed
      130. Brew BJ, Price RW. Another retroviral disease of the nervous system: chronic progressive myelopathy due to HTLV-1. N Engl J Med. 1988 May 5; 318(18):1195-7.
        View in: PubMed
      131. Tross S, Price RW, Navia B, Thaler HT, Gold J, Hirsch DA, Sidtis JJ. Neuropsychological characterization of the AIDS dementia complex: a preliminary report. AIDS. 1988 Apr; 2(2):81-8.
        View in: PubMed
      132. Price RW, Brew B, Sidtis J, Rosenblum M, Scheck AC, Cleary P. The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. Science. 1988 Feb 5; 239(4840):586-92.
        View in: PubMed
      133. Price RW, Brew B. Infection of the central nervous system by human immunodeficiency virus. Role of the immune system in pathogenesis. Ann N Y Acad Sci. 1988; 540:162-75.
        View in: PubMed
      134. Aronow HA, Brew BJ, Price RW. The management of the neurological complications of HIV infection and AIDS. AIDS. 1988; 2 Suppl 1:S151-9.
        View in: PubMed
      135. Brew BJ, Rosenblum M, Price RW. Pathogenetic implications of neuropathological findings in the AIDS dementia complex. Psychopharmacol Bull. 1988; 24(3):307-10.
        View in: PubMed
      136. Rottenberg DA, Moeller JR, Strother SC, Sidtis JJ, Navia BA, Dhawan V, Ginos JZ, Price RW. The metabolic pathology of the AIDS dementia complex. Ann Neurol. 1987 Dec; 22(6):700-6.
        View in: PubMed
      137. Pumarola-Sune T, Navia BA, Cordon-Cardo C, Cho ES, Price RW. HIV antigen in the brains of patients with the AIDS dementia complex. Ann Neurol. 1987 May; 21(5):490-6.
        View in: PubMed
      138. Navia BA, Price RW. The acquired immunodeficiency syndrome dementia complex as the presenting or sole manifestation of human immunodeficiency virus infection. Arch Neurol. 1987 Jan; 44(1):65-9.
        View in: PubMed
      139. Petito CK, Cho ES, Lemann W, Navia BA, Price RW. Neuropathology of acquired immunodeficiency syndrome (AIDS): an autopsy review. J Neuropathol Exp Neurol. 1986 Nov; 45(6):635-46.
        View in: PubMed
      140. Doro S, Navia BA, Kahn A, Pumarola-Sune T, Price RW. Confirmation of HTLV-III virus in cornea. Am J Ophthalmol. 1986 Sep 15; 102(3):390-1.
        View in: PubMed
      141. Navia BA, Cho ES, Petito CK, Price RW. The AIDS dementia complex: II. Neuropathology. Ann Neurol. 1986 Jun; 19(6):525-35.
        View in: PubMed
      142. Navia BA, Jordan BD, Price RW. The AIDS dementia complex: I. Clinical features. Ann Neurol. 1986 Jun; 19(6):517-24.
        View in: PubMed
      143. Navia BA, Petito CK, Gold JW, Cho ES, Jordan BD, Price RW. Cerebral toxoplasmosis complicating the acquired immune deficiency syndrome: clinical and neuropathological findings in 27 patients. Ann Neurol. 1986 Mar; 19(3):224-38.
        View in: PubMed
      144. Price RW, Navia BA, Cho ES. AIDS encephalopathy. Neurol Clin. 1986 Feb; 4(1):285-301.
        View in: PubMed
      145. Petito CK, Navia BA, Cho ES, Jordan BD, George DC, Price RW. Vacuolar myelopathy pathologically resembling subacute combined degeneration in patients with the acquired immunodeficiency syndrome. N Engl J Med. 1985 Apr 4; 312(14):874-9.
        View in: PubMed
      146. Shaw GM, Harper ME, Hahn BH, Epstein LG, Gajdusek DC, Price RW, Navia BA, Petito CK, O'Hara CJ, Groopman JE, et al. HTLV-III infection in brains of children and adults with AIDS encephalopathy. Science. 1985 Jan 11; 227(4683):177-82.
        View in: PubMed
      147. Jordan BD, Navia BA, Petito C, Cho ES, Price RW. Neurological syndromes complicating AIDS. Front Radiat Ther Oncol. 1985; 19:82-7.
        View in: PubMed
      148. Saito Y, Price RW. Enhanced regional uptake of 2-deoxy-D-[14C]glucose in focal herpes simplex type 1 encephalitis: autoradiographic study in the rat. Neurology. 1984 Mar; 34(3):276-84.
        View in: PubMed
      149. Epstein LG, Sharer LR, Cho ES, Myenhofer M, Navia B, Price RW. HTLV-III/LAV-like retrovirus particles in the brains of patients with AIDS encephalopathy. AIDS Res. 1984-1985; 1(6):447-54.
        View in: PubMed
      150. Price RW, Nielsen S, Horten B, Rubino M, Padgett B, Walker D. Progressive multifocal leukoencephalopathy: a burnt-out case. Ann Neurol. 1983 May; 13(5):485-90.
        View in: PubMed
      151. Tsukamoto LF, Price RW. Interferon protects neurons in culture infected with vesicular stomatitis and herpes simplex viruses. J Neurol Sci. 1982 Oct; 56(1):115-28.
        View in: PubMed
      152. Willoughby E, Price RW, Padgett BL, Walker DL, Dupont B. Progressive multifocal leukoencephalopathy (PML): in vitro cell-mediated immune responses to mitogens and JC virus. Neurology. 1980 Mar; 30(3):256-62.
        View in: PubMed
      153. Walz MA, Price RW, Hayashi K, Katz BJ, Notkins AL. Effect of immunization on acute and latent infections of vaginouterine tissue with herpes simplex virus types 1 and 2. J Infect Dis. 1977 May; 135(5):744-52.
        View in: PubMed
      154. Price RW. Viral infections of the autonomic nervous system and its target organs: pathogenetic mechanisms. Med Hypotheses. 1977 Jan-Feb; 3(1):33-6.
        View in: PubMed
      155. Walz MA, Price RW, Notkins AL. Latent ganglionic infection with herpes simplex virus types 1 and 2: viral reactivation in vivo after neurectomy. Science. 1974 Jun 14; 184(4142):1185-7.
        View in: PubMed
      Richard's Networks
      Related Concepts
      Derived automatically from this person's publications.
      _
      Co-Authors
      People in Profiles who have published with this person.
      _
      Related Authors
      People who share related concepts with this person.
      _
      Same Department
      Back to TOP